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Effect of male circumcision on risk of sexually transmitted 
infections and cervical cancer in women
Current scientific evidence demonstrates compellingly that 
male circumcision confers a lifetime of medical and health 
benefits to men.1 Are there also any benefits for women 
who have a male sexual partner who is circumcised?
In The Lancet Global Health, researchers from the US 
Centers for Disease Control and Prevention and Johns 
Hopkins University report results of a systematic review2 
that directly addresses the question of whether male 
circumcision reduces acquisition of sexually transmitted 
infections (STIs) and cervical cancer in women. Clearly, 
reduced population prevalence of STIs in men will 
translate into lower risk of STI exposure in women. But 
will circumcised men with STIs be less infective?
Jonathan Grund and colleagues’ extensive search of nine 
literature databases generated 112 eligible publications, 
of which 60 reported quantitative biomedical health 
outcomes and 57 were included. Of these, most studies 
were observational and nine were randomised controlled 
trials (RCTs). Women were from populations in Africa, 
North America, South America, Asia, and Europe. Their 
ages spanned from either 15 or 18 years through to either 
49 or 65 years.
Strong, consistent evidence was found for protection 
against cervical cancer (eight of nine studies involving 
women in multiple non-African settings), cervical 
dysplasia (four of five studies involving women in Africa 
and other continents), herpes simplex virus type 2 
infection (six of six studies, including one RCT, involving 
women in Africa, Asia, and the USA), chlamydia (four of 
five studies, involving women in five continents), and 
syphilis (six of six studies, involving women in Africa and 
Asia).
Persistent human papillomavirus (HPV) infection is 
the cause of almost all cervical cancers. Women with 
circumcised partners were protected against any HPV 
(five of five studies including three RCTs, involving 
women from multiple settings in Africa and Europe) and 
low-risk HPV types (three of three studies, two being 
RCTs, involving women in Africa and Europe). These 
HPV findings stemmed from medium-consistency 
evidence.
For six outcomes—protection against any STI, 
candidiasis, dysuria, genital warts, gonorrhoea, high-risk 
HPV viral load, and Mycoplasma genitalium—evidence was 
regarded as intermediate consistency because there were 
fewer than the minimum of three studies required for 
medium consistency. Seven other outcomes—bacterial 
vaginosis, gonorrhoea, HIV infection, high-risk HPV 
infection, non-specific genital ulcers, trichomonas, and 
vaginal discharge—had discrepant values, which rendered 
the evidence as low-consistency. 
Over her lifetime, a woman might have sexual 
partners of either male circumcision status, potentially 
confounding associations between male partner’s 
circumcision status and a woman’s HPV risk. A noteworthy 
global multinational study of HPV and cervical cancer 
obtained data for women who had had only one male 
partner.3 Sampling of urethra and glans or coronal sulcus 
revealed HPV infection in 5·5% of circumcised versus 
19·6% of uncircumcised men.3 Among women who had 
a high-risk sexual partner (defined as one who had had 
≥6 sexual partners and first intercourse before the age of 
17 years), cervical cancer was 82% less prevalent if that 
partner was circumcised than if he was uncircumcised. 
Reduction of cervical cancer risk from circumcision 
was 50% for women whose male partner had an 
intermediate risk index. Analysis of this multinational 
dataset4 demonstrated that male circumcision conferred 
a 79% reduction in the risk of Chlamydia trachomatis 
infection for single-partnered women whose lifetime 
partner tested positive for this STI. The authors speculated 
that infected cervicovaginal secretions might be retained 
under the foreskin of an uncircumcised penis for longer, 
so increasing risk of urethral infection and transmission to 
a subsequent female partner.4
A study5 of women in Kenya and Uganda enrolled in an 
RCT and followed up for 3 years found circumcision of 
their male partners was associated with a 59% reduction 
in incident syphilis among the women. A prospective 
study6 in Kenya by the same authors found that those 
with circumcised male partners had a 58% lower risk 
of incident Trachomatis vaginalis than did women with 
uncircumcised partners.6 
The systematic review2 emphasises that male 
circumcision confers an STI risk reduction to women. 
Prophylactic vaccines against HIV and most other 
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STIs have remained elusive. HPV vaccination against 
a subset of HPV types in early adolescence can help to 
partly mitigate cervical cancer risk, but uptake is not 
widespread in all settings. The emerging switch from 
Papanicolaou smears to primary screening for HPV7 in 
high-income countries will improve risk detection, but 
is not practicable in resource-constrained settings. Thus, 
although the diagnosis and treatment of STIs continue 
to improve in effectiveness, prevention has to remain 
a priority for many reasons, not the least of which is 
cost.
The benefits of male circumcision for men are 
well established, with the science driving affirmative 
policy recommendations by WHO, UNAIDS, the World 
Bank, the American Academy of Pediatrics, and the 
US Centers for Disease Control and Prevention. The 
findings of this systematic review support affirmative 
policy recommendations for women. Women can have 
considerable power in regard to male circumcision. They 
can and do influence the choice of male circumcision 
for their sons ideally soon after birth,8 and later, as well 
as for their brothers and other male family members. 
Women can choose a circumcised sexual partner or 
encourage an uncircumcised partner to get circumcised. 
Most studies, including an RCT,9 have noted that 
women generally favour male circumcision for aesthetic 
reasons, sexual pleasure, vaginal penetration, hygiene, 
and reduced infection risk.
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